Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80,437,135
-
Total 13F shares
-
29,224,066
-
Share change
-
+734,996
-
Total reported value
-
$409,245,732
-
Put/Call ratio
-
127%
-
Price per share
-
$14.01
-
Number of holders
-
110
-
Value change
-
+$31,590,352
-
Number of buys
-
56
-
Number of sells
-
49
Institutional Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q3 2016
As of 30 Sep 2016,
PTC THERAPEUTICS, INC. - Common Stock (PTCT) was held by
110 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
29,224,066 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, CAMBER CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, BlackRock Fund Advisors, BB BIOTECH AG, TOCQUEVILLE ASSET MANAGEMENT L.P., FRONTIER CAPITAL MANAGEMENT CO LLC, BlackRock Institutional Trust Company, N.A., Sectoral Asset Management Inc, and D. E. Shaw & Co., Inc..
This page lists
110
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.